Dimitri Gerostamoulos

Prof. Dr. Dimitri Gerostamoulos

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2007 in Forensic Science International
Verified
Journal Article
Closed access
ODOlaf H. Drummer
Olaf H. Drummer
DGDimitri Gerostamoulos
Dimitri Gerostamoulos
MCMark Chu
Mark Chu
PSPhilip Swann
Philip Swann
MBMartin Boorman
Martin Boorman
ICIan Cairns
Ian Cairns

22 May 2012 in Forensic Science, Medicine and Pathology
Verified
Journal Article
Closed access
PDF file
DGDimitri Gerostamoulos
Dimitri Gerostamoulos
JBJochen Beyer
Jochen Beyer
VSVoula Staikos
Voula Staikos
PTPenny Tayler
Penny Tayler
NWNoel Woodford
Noel Woodford
ODOlaf H. Drummer
Olaf H. Drummer

1 October 2017 in Forensic Science International
Verified
Journal Article
Closed access
VBVassiliki Boumba
Vassiliki Boumba
MRMatthew Di Rago
Matthew Di Rago
MPMelissa Peka
Melissa Peka
ODOlaf H. Drummer
Olaf H. Drummer
DGDimitri Gerostamoulos
Dimitri Gerostamoulos

1 May 2019 in Forensic Science International
Verified
Journal Article
Closed access
ODOlaf H. Drummer
Olaf H. Drummer
DGDimitri Gerostamoulos
Dimitri Gerostamoulos
NWNoel W. Woodford
Noel W. Woodford

20 July 2010 in Journal of Mass Spectrometry
Verified
Journal Article
Closed access
PDF file
ESEva Saar
Eva Saar
DGDimitri Gerostamoulos
Dimitri Gerostamoulos
ODOlaf H. Drummer
Olaf H. Drummer
JBJochen Beyer
Jochen Beyer

16 May 2012 in Journal of Analytical Toxicology
Verified
Journal Article
Open access
PDF file
JAJulia Ammann
Julia Ammann
JMJenna M. McLaren
Jenna M. McLaren
DGDimitri Gerostamoulos
Dimitri Gerostamoulos
JBJochen Beyer
Jochen Beyer
Synthetic cannabinoids sprayed on herbal mixtures have been abused as a new designer drug all over the world since 2004. In 2008, the first compounds, CP 47,497 and JWH-018, were identified as active ingredients in these mixtures. Most of the compounds have been synthesized for research purposes and are potent CB1 and/or CB2 receptor agonists. To investigate the presence of synthetic cannabinoids in blood samples, a liquid chromatography–tandem mass spectrometry (LC–MS-MS) method was developed using only 100 µL of blood. After the addition of 0.2 mL of trizma buffer, the blood was extracted using liquid–liquid extraction with 1 mL of 1-chlorobutane containing 10% of isopropanol for 5 min on a shaker at 1,500 rpm. After centrifugation at 12,000 rpm for 1 min, the separated solvent layer was transferred to an autosampler vial and evaporated to dryness under N2. The residue was reconstituted in methanol and injected into a Shimadzu 8030 LC–MS-MS system to separate and detect 25 synthetic cannabinoids. The method has been validated according to international guidelines and was found to be selective for all tested compounds. Calibration was satisfactory from 0.5–100 ng/mL, and from 5.0–500 ng/mL. for HU-210, CP 47,497 and the CP 47,497 C-8 homolog, respectively. The extraction efficiencies ranged from 30–101% and the matrix effects from 67–112%. Accuracy data were within the acceptance interval of ±15% (±20% at the lower limit of quantification) of the nominal values for all drugs.